Now showing items 1-1 of 1

    • Novel monoclonal antibodies targeting conformational ERBB2 epitopes 

      Ceran, Ceyhan (Bilkent University, 2012)
      ERBB2 is a tyrosine kinase receptor which can act as homodimers or heterodimers with other members of the ERBB family. Nearly 30% of breast cancers overexpress ERBB2, which can be effectively targeted by anti-ERBB2 monoclonal ...